119 related articles for article (PubMed ID: 38179758)
1. RIPK4 Promotes Cell Invasion and the Epithelial-Mesenchymal Transition in Ovarian Cancer.
Hua L; Wu JH; Xu JY; Wu SG; Zhou J
Front Biosci (Landmark Ed); 2023 Dec; 28(12):368. PubMed ID: 38179758
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of RIPK4 Expression Inhibits Epithelial-Mesenchymal Transition in Ovarian Cancer through IL-6.
Yi H; Su YZ; Lin R; Zheng XQ; Pan D; Lin DM; Gao X; Zhang R
J Immunol Res; 2021; 2021():8875450. PubMed ID: 33855091
[TBL] [Abstract][Full Text] [Related]
3. Receptor interacting protein kinase 4 promotes cell proliferation, migration, and invasion in ovarian cancer via targeting protein kinase C delta.
Jin A; Zhang L; Fang G; Chen Y
Drug Dev Res; 2022 Apr; 83(2):407-415. PubMed ID: 34414590
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of RIPK4 Predicts Poor Prognosis and Promotes Metastasis in Ovarian Cancer.
Liu S; He L; Sheng C; Su R; Wu X; Sun Y; Xi X
Biomed Res Int; 2021; 2021():6622439. PubMed ID: 34124253
[TBL] [Abstract][Full Text] [Related]
5. Silencing of RIPK4 inhibits epithelial‑mesenchymal transition by inactivating the Wnt/β‑catenin signaling pathway in osteosarcoma.
Yi Z; Pu Y; Gou R; Chen Y; Ren X; Liu W; Dong P
Mol Med Rep; 2020 Mar; 21(3):1154-1162. PubMed ID: 32016450
[TBL] [Abstract][Full Text] [Related]
6. TRAP1 downregulation in human ovarian cancer enhances invasion and epithelial-mesenchymal transition.
Amoroso MR; Matassa DS; Agliarulo I; Avolio R; Lu H; Sisinni L; Lettini G; Gabra H; Landriscina M; Esposito F
Cell Death Dis; 2016 Dec; 7(12):e2522. PubMed ID: 27977010
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA miR-330-3p suppresses the progression of ovarian cancer by targeting RIPK4.
Cai L; Ye L; Hu X; He W; Zhuang D; Guo Q; Shu K; Jie Y
Bioengineered; 2021 Dec; 12(1):440-449. PubMed ID: 33487072
[TBL] [Abstract][Full Text] [Related]
8. Wilms' tumor 1 (
Han Y; Song C; Zhang T; Zhou Q; Zhang X; Wang J; Xu B; Zhang X; Liu X; Ying X
Cell Cycle; 2020 Oct; 19(20):2662-2675. PubMed ID: 32892698
[TBL] [Abstract][Full Text] [Related]
9. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
[No Abstract] [Full Text] [Related]
10. RIPK4 Is an Immune Regulating-Associated Biomarker for Ovarian Cancer and Possesses Generalization Value in Pan-Cancer.
Liao C; Zhao YX; Han WD; Lai NY
J Immunol Res; 2022; 2022():7599098. PubMed ID: 35310605
[TBL] [Abstract][Full Text] [Related]
11. The Overexpression of Keratin 23 Promotes Migration of Ovarian Cancer via Epithelial-Mesenchymal Transition.
Ren M; Gao Y; Chen Q; Zhao H; Zhao X; Yue W
Biomed Res Int; 2020; 2020():8218735. PubMed ID: 33204716
[TBL] [Abstract][Full Text] [Related]
12. Knocking down Sterol regulatory element binding protein 2 (SREBF2) inhibits the Serine Protease 8 (PRSS8) /sodium channel epithelial 1alpha subunit (SCNN1A) axis to reduce the cell proliferation, migration and epithelial-mesenchymal transformation of ovarian cancer.
Cai C; Zhang Y; Peng X
Bioengineered; 2021 Dec; 12(2):9390-9400. PubMed ID: 34823420
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of SPINK13 Promotes Metastasis by Regulating uPA in Ovarian Cancer Cells.
Cai S; Zhang P; Dong S; Li L; Cai J; Xu M
Cell Physiol Biochem; 2018; 45(3):1061-1071. PubMed ID: 29439245
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of PADI2 prevents proliferation and epithelial-mesenchymal transition in ovarian cancer through inhibiting JAK2/STAT3 pathway in vitro and in vivo, alone or in combination with Olaparib.
Liu L; Zhang Z; Zhang G; Wang T; Ma Y; Guo W
J Transl Med; 2020 Sep; 18(1):357. PubMed ID: 32951601
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of
Wu L; Ling ZH; Wang H; Wang XY; Gui J
Cancer Biother Radiopharm; 2019 Dec; 34(10):642-649. PubMed ID: 31549859
[No Abstract] [Full Text] [Related]
16. circ-CSPP1 promotes proliferation, invasion and migration of ovarian cancer cells by acting as a miR-1236-3p sponge.
Li QH; Liu Y; Chen S; Zong ZH; Du YP; Sheng XJ; Zhao Y
Biomed Pharmacother; 2019 Jun; 114():108832. PubMed ID: 30965236
[TBL] [Abstract][Full Text] [Related]
17. LncRNA MIR31HG promotes cell proliferation and invasive properties of the MCF-7 cell line by regulation of receptor-interacting serine-threonine kinase 4.
Tang J; Zhang X; Chen C; Wang B; Chen Y; Zhang H; Qiao M; Liu X; Guo W; Jin G
Acta Biochim Pol; 2023 Dec; 70(4):935-941. PubMed ID: 38064252
[TBL] [Abstract][Full Text] [Related]
18. UBE2T is upregulated, predicts poor prognosis, and promotes cell proliferation and invasion by promoting epithelial-mesenchymal transition via inhibiting autophagy in an AKT/mTOR dependent manner in ovarian cancer.
Huang W; Huang H; Xiao Y; Wang L; Zhang T; Fang X; Xia X
Cell Cycle; 2022 Apr; 21(8):780-791. PubMed ID: 35130130
[TBL] [Abstract][Full Text] [Related]
19. A transcription factor that promotes proliferation, migration, invasion, and epithelial-mesenchymal transition of ovarian cancer cells and its possible mechanisms.
Qi Y; Mo K; Zhang T
Biomed Eng Online; 2021 Aug; 20(1):83. PubMed ID: 34399777
[TBL] [Abstract][Full Text] [Related]
20. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]